Deciphering the Precise Role of Complement Activation in IgA Nephropathy to Develop Therapeutic Inhibitors
Time: 11:45 am
day: Pre-Conference Seminar Day
Details:
- Discussing the role of the complement cascade in the pathogenesis of IgA nephropathy
- Review results of the Phase II trial of RO7434656, an antisense oligonucleotide targeting complement
- Providing an overview of the Phase III IMAgINATION trial of RO7434656 in patients with IgA nephropathy
